Breakthroughs in C-MET Metastatic Non-small Cell Lung Cancer: Market to Surge by 2034 | DelveInsight
With trailblazers like Novartis, Merck, EMD Serono, and AbbVie at the helm, innovative therapies are transforming patient care. LAS VEGAS , NV, UNITED STATES, February 5, 2025 /EINPresswire.com/ -- DelveInsight’s “C-MET Metastatic Non-small …